September 2013 Issue of MMM
SEPTEMBER 2013 ISSUE
HCPs are viewing more content than before—but probably not your content
Click the above link to access the complete Digital Edition of the August 2013 issue, with all text, charts and pictures.
Marketers say emotion is the spark with which audiences most identify. Marc Iskowitz on five campaigns that connect with consumers
No one expected the numbers to be pretty. And medical/surgical journals' latest losses weren't. Larry Dobrow analyzes the numbers for the first half of 2013 ...
Generics aren't just ANDAs and patent challenges. Kathy Kovalic on how Marketing and R&D must create a product's value proposition
Seven industry experts evaluate advances and opportunities in non-personal promotion to physicians, and debate whether brands really need to deploy sales forces. James Chase chairs ...
Maggie FitzPatrick, CCO/VP, public affairs and corporate communication, J&J
Companies in this space are expanding beyond reproductive health into areas like menopause and osteoporosis. To succeed, they'll need to re-energize their physician and patient ...
A quiet revolution is underway in research to keep pace with changes in medical marketing
A new study about copper's role as a possible contributing factor in the development of Alzeheimer's Disease has come in just below the media radar, ...
Data-sharing advocates have been calling on manufacturers to release the raw data from clinical trials so that researchers can look at all the parameters related ...
Education around the Sunshine Act has been ongoing, and a number of organizations are seeking to help physicians stay up-to-speed with the requirements
A study by consulting research firm ZS Associates shows the wedge between oncologists and sales reps has gotten so large that oncology is the most ...
News on Vivus, Bristol-Myers Squibb and GlaxoSmithKline
Med Ed Report
Though CME grant-giving dropped by about 10% in 2012, revenues from regsitration fees and the like surged nearly 15%
Haymarket Medical Education is taking the wraps off a totally redesigned MyCME.com portal this month
The AAFP has urged FDA to keep REMS-specific CME for extended-release and long-acting opioids voluntary
News about Pri-Med, Astellas Scientic, Medical Affairs, UCSD and CircleScience
MedPage Today's new VP and global editorial director, Ivan Oransky, has a goal in mind: to make the resource even more top-of-mind among the medical ...
A study published in JAMA Internal Medicine shows that encouraging patients to read up on a topic beforehand could make office visits more productive
News on JAMA Ophthalmology, the New England Journal of Medicine, Elsevier and Oxford University Press
Patients and physicians each can benefit from gamification: Patients gain a sense of control and connection, physicians can boost competencies. How can games foster better ...
Merck's Global Health Innovation Fund (GHIF) expanded its stake in digital physician marketing firm Physicians Interactive last month, buying a controlling interest from previous majority ...
Toronto-based Klick Health dismissed most of its North American sales staff earlier this year
News on Manhattan Research, WebMD, Proteus Digital Health and the Parkinson Foundation
Astellas rolled out "OAB Reality," an unbranded campaign as a way to answer common questions about overactive bladder
In a big step that shows how DTC can be a key tool to drive business, small biotech firm Dendreon has launched a campaign for ...
Personal genetics firm 23andMe aired its first TV ad last month in a bid to build the audience for DNA sequencing.
Symphony Health Solutions filed an antitrust lawsuit against IMS Health, accusing it of trying to monopolize the pharma data and analytics market
The NIH said it will fund up to $24 million per year for four years to establish six to eight Big Data to Knowledge (BD2K) ...
InVentiv Health Communications (iMC) expanded its brainpower's reach to include New York and Tokyo, adding to existing locations in Dallas, Philadelphia, London, Paris, Munich and ...
PR Firm Weber Shandwick announced that Susan Smirnoff will join its health practice as EVP/senior counselor
News on Giant Creative/Strategy, Tonic Life Communications, Coyne Public Relations and Spectrum Science
CMS recognized that the rules in place for CME provide for separation from supporter influence
The Federal Trade Commission (FTC) says that a June Supreme Court decision finding so-called pay-for-delay patent dispute settlements not inherently anticompetitive has put the agency ...
A study of prescription drug direct-to-consumer advertising suggests that it may promote over-diagnosis of high cholesterol and over-treatment for populations where risks of statin use ...
Pharma, hospitals and payers need to apply insights and data to create more meaningful interactions
Images that dramatize physical problems with an almost nightmarish spin make for compelling brand messages in six top-notch advertisements
David Cherry, Chief digital officer, Sudler & Hennessey
At Work With
Graham Mills, Managing director, Digitas Health
Manufacturer, agency and research promotions and hires
Contextual awareness can mobilize patients' relationships to a brand
- The 2017 pipeline report: What to know about next year's launches
- Five things for pharma marketers to know: Monday, November 28, 2016
- Lilly's branded app for Trulicity looks to address adherence
- Lawmakers cut CME exemption from 21st Century Cures Act
- Five things for pharma marketers to know: Tuesday, November 29, 2016
- Boehringer Ingelheim launches gamified support program
- Omnicom merges AgencyRx, Flashpoint and three other agencies to form DDB Health
- No free lunch for docs: Sponsored meals linked to more prescriptions
- Non-profit behind Free Killer Tan wants parents to practice sun safety
- Allergan draws on A-list celebs to drive engagement
- Five things for pharma marketers to know: Monday, December 5, 2016
- Prescription drug spending rises 9% in 2015, to $324 billion
- As users move to mobile, Google says they made 200 million queries for info about cancer drugs
- Five things for pharma marketers to know: Friday, December 2, 2016
- Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.